Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
public health
Pharma
Merck eyes COVID antiviral Lagevrio amid Ebola outbreak
Merck & Co. is considering dusting off its antiviral molnupiravir, previously authorized as a COVID-19 treatment, to meet the current Ebola outbreak.
Fraiser Kansteiner
Jun 2, 2026 10:40am
Eli Lilly delivers $50M boost to UNICEF’s pediatric health push
May 14, 2026 11:33am
Fierce Healthcare
States' lawsuit against RFK Jr.'s HHS overhaul moves forward
Apr 9, 2026 7:30am
Fierce Healthcare
Providers' lawsuit against RFK Jr.'s ACIP changes moves forward
Jan 7, 2026 11:00am
Fierce Biotech
'Why We Vaccinate': BIO targets lawmakers for immunization push
Oct 20, 2025 1:50pm
Fierce Healthcare
ACIP's vaccine guidance sows confusion, health experts say
Sep 23, 2025 3:30pm